Literature DB >> 25317951

Comparative study of outcome measures and analysis methods for traumatic brain injury trials.

Aziz S Alali1, Darcy Vavrek, Jason Barber, Sureyya Dikmen, Avery B Nathens, Nancy R Temkin.   

Abstract

Batteries of functional and cognitive measures have been proposed as alternatives to the Extended Glasgow Outcome Scale (GOSE) as the primary outcome for traumatic brain injury (TBI) trials. We evaluated several approaches to analyzing GOSE and a battery of four functional and cognitive measures. Using data from a randomized trial, we created a "super" dataset of 16,550 subjects from patients with complete data (n=331) and then simulated multiple treatment effects across multiple outcome measures. Patients were sampled with replacement (bootstrapping) to generate 10,000 samples for each treatment effect (n=400 patients/group). The percentage of samples where the null hypothesis was rejected estimates the power. All analytic techniques had appropriate rates of type I error (≤5%). Accounting for baseline prognosis either by using sliding dichotomy for GOSE or using regression-based methods substantially increased the power over the corresponding analysis without accounting for prognosis. Analyzing GOSE using multivariate proportional odds regression or analyzing the four-outcome battery with regression-based adjustments had the highest power, assuming equal treatment effect across all components. Analyzing GOSE using a fixed dichotomy provided the lowest power for both unadjusted and regression-adjusted analyses. We assumed an equal treatment effect for all measures. This may not be true in an actual clinical trial. Accounting for baseline prognosis is critical to attaining high power in Phase III TBI trials. The choice of primary outcome for future trials should be guided by power, the domain of brain function that an intervention is likely to impact, and the feasibility of collecting outcome data.

Entities:  

Keywords:  Glasgow Outcome Scale; outcome measures; research design; statistical data analysis; traumatic brain injury

Mesh:

Year:  2015        PMID: 25317951      PMCID: PMC4394163          DOI: 10.1089/neu.2014.3495

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  35 in total

Review 1.  Clinical trials in head injury.

Authors:  Raj K Narayan; Mary Ellen Michel; Beth Ansell; Alex Baethmann; Anat Biegon; Michael B Bracken; M Ross Bullock; Sung C Choi; Guy L Clifton; Charles F Contant; William M Coplin; W Dalton Dietrich; Jamshid Ghajar; Sean M Grady; Robert G Grossman; Edward D Hall; William Heetderks; David A Hovda; Jack Jallo; Russell L Katz; Nachshon Knoller; Patrick M Kochanek; Andrew I Maas; Jeannine Majde; Donald W Marion; Anthony Marmarou; Lawrence F Marshall; Tracy K McIntosh; Emmy Miller; Noel Mohberg; J Paul Muizelaar; Lawrence H Pitts; Peter Quinn; Gad Riesenfeld; Claudia S Robertson; Kenneth I Strauss; Graham Teasdale; Nancy Temkin; Ronald Tuma; Charles Wade; Michael D Walker; Michael Weinrich; John Whyte; Jack Wilberger; A Byron Young; Lorraine Yurkewicz
Journal:  J Neurotrauma       Date:  2002-05       Impact factor: 5.269

2.  Assessing proportionality in the proportional odds model for ordinal logistic regression.

Authors:  R Brant
Journal:  Biometrics       Date:  1990-12       Impact factor: 2.571

Review 3.  Validity of composite end points in clinical trials.

Authors:  Victor M Montori; Gaietà Permanyer-Miralda; Ignacio Ferreira-González; Jason W Busse; Valeria Pacheco-Huergo; Dianne Bryant; Jordi Alonso; Elie A Akl; Antònia Domingo-Salvany; Edward Mills; Ping Wu; Holger J Schünemann; Roman Jaeschke; Gordon H Guyatt
Journal:  BMJ       Date:  2005-03-12

4.  Validity and sensitivity to change of the extended Glasgow Outcome Scale in mild to moderate traumatic brain injury.

Authors:  H S Levin; C Boake; J Song; S Mccauley; C Contant; P Diaz-Marchan; S Brundage; H Goodman; K J Kotrla
Journal:  J Neurotrauma       Date:  2001-06       Impact factor: 5.269

Review 5.  Analyzing outcome of treatment of severe head injury: a review and update on advancing the use of the Glasgow Outcome Scale.

Authors:  G M Teasdale; L E Pettigrew; J T Wilson; G Murray; B Jennett
Journal:  J Neurotrauma       Date:  1998-08       Impact factor: 5.269

6.  Structured interviews for the Glasgow Outcome Scale and the extended Glasgow Outcome Scale: guidelines for their use.

Authors:  J T Wilson; L E Pettigrew; G M Teasdale
Journal:  J Neurotrauma       Date:  1998-08       Impact factor: 5.269

7.  Cognitive sequelae of severe head injury in relation to the Glasgow Outcome Scale.

Authors:  D N Brooks; J Hosie; M R Bond; B Jennett; M Aughton
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-05       Impact factor: 10.154

8.  Tissue plasminogen activator for acute ischemic stroke.

Authors: 
Journal:  N Engl J Med       Date:  1995-12-14       Impact factor: 91.245

9.  The Galveston Orientation and Amnesia Test. A practical scale to assess cognition after head injury.

Authors:  H S Levin; V M O'Donnell; R G Grossman
Journal:  J Nerv Ment Dis       Date:  1979-11       Impact factor: 2.254

10.  Outcome 3 to 5 years after moderate to severe traumatic brain injury.

Authors:  Sureyya S Dikmen; Joan E Machamer; Janet M Powell; Nancy R Temkin
Journal:  Arch Phys Med Rehabil       Date:  2003-10       Impact factor: 3.966

View more
  14 in total

1.  Glasgow Outcome Scale Measures and Impact on Analysis and Results of a Randomized Clinical Trial of Severe Traumatic Brain Injury.

Authors:  Jose-Miguel Yamal; H Julia Hannay; Shankar Gopinath; Imoigele P Aisiku; Julia S Benoit; Claudia S Robertson
Journal:  J Neurotrauma       Date:  2019-05-23       Impact factor: 5.269

2.  Prognostic value of day-of-injury plasma GFAP and UCH-L1 concentrations for predicting functional recovery after traumatic brain injury in patients from the US TRACK-TBI cohort: an observational cohort study.

Authors:  Frederick K Korley; Sonia Jain; Xiaoying Sun; Ava M Puccio; John K Yue; Raquel C Gardner; Kevin K W Wang; David O Okonkwo; Esther L Yuh; Pratik Mukherjee; Lindsay D Nelson; Sabrina R Taylor; Amy J Markowitz; Ramon Diaz-Arrastia; Geoffrey T Manley
Journal:  Lancet Neurol       Date:  2022-09       Impact factor: 59.935

3.  Predicting Clinical Outcomes 7-10 Years after Severe Traumatic Brain Injury: Exploring the Prognostic Utility of the IMPACT Lab Model and Cerebrospinal Fluid UCH-L1 and MAP-2.

Authors:  Adrian M Svingos; Steven A Robicsek; Ronald L Hayes; Kevin K Wang; Claudia S Robertson; Gretchen M Brophy; Linda Papa; Andrea Gabrielli; H Julia Hannay; Russell M Bauer; Shelley C Heaton
Journal:  Neurocrit Care       Date:  2022-03-01       Impact factor: 3.532

Review 4.  Developing a Cognition Endpoint for Traumatic Brain Injury Clinical Trials.

Authors:  Noah D Silverberg; Paul K Crane; Kristen Dams-O'Connor; James Holdnack; Brian J Ivins; Rael T Lange; Geoffrey T Manley; Michael McCrea; Grant L Iverson
Journal:  J Neurotrauma       Date:  2016-06-27       Impact factor: 5.269

5.  Testing a Multivariate Proteomic Panel for Traumatic Brain Injury Biomarker Discovery: A TRACK-TBI Pilot Study.

Authors:  J Russell Huie; Ramon Diaz-Arrastia; John K Yue; Marco D Sorani; Ava M Puccio; David O Okonkwo; Geoffrey T Manley; Adam R Ferguson
Journal:  J Neurotrauma       Date:  2018-09-27       Impact factor: 5.269

6.  Functional Status Examination Yields Higher Measurement Precision of Functional Limitations after Traumatic Injury than the Glasgow Outcome Scale-Extended: A Preliminary Study.

Authors:  Lindsay D Nelson; Benjamin L Brett; Brooke E Magnus; Steve Balsis; Michael A McCrea; Geoffrey T Manley; Nancy Temkin; Sureyya Dikmen
Journal:  J Neurotrauma       Date:  2019-11-13       Impact factor: 5.269

Review 7.  The Glasgow Outcome Scale - 40 years of application and refinement.

Authors:  Tom McMillan; Lindsay Wilson; Jennie Ponsford; Harvey Levin; Graham Teasdale; Michael Bond
Journal:  Nat Rev Neurol       Date:  2016-07-15       Impact factor: 42.937

8.  Sliding Scoring of the Glasgow Outcome Scale-Extended as Primary Outcome in Traumatic Brain Injury Trials.

Authors:  Sharon D Yeatts; Reneé H Martin; William Meurer; Robert Silbergleit; Gaylan L Rockswold; William G Barsan; Frederick K Korley; David W Wright; Byron J Gajewski
Journal:  J Neurotrauma       Date:  2020-08-26       Impact factor: 5.269

Review 9.  Progesterone for acute traumatic brain injury.

Authors:  Junpeng Ma; Siqing Huang; Shu Qin; Chao You; Yunhui Zeng
Journal:  Cochrane Database Syst Rev       Date:  2016-12-22

Review 10.  Embracing failure: What the Phase III progesterone studies can teach about TBI clinical trials.

Authors:  Donald G Stein
Journal:  Brain Inj       Date:  2015-08-14       Impact factor: 2.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.